You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Refractory, progressive, or relapsed HIV NHL

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

SALVAGE TREATMENT WITH GLOFITAMAB IN RELAPSED/REFRACTORY B-NHL:

Not yet recruiting
  • B-cell Non Hodgkin Lymphoma
  • +2 more
    • (no location specified)
    Jun 22, 2023

    NHL, NHL, Relapsed, Adult Trial in United States (CLN-978)

    Recruiting
    • NHL
    • NHL, Relapsed, Adult
    • Birmingham, Alabama
    • +4 more
    May 31, 2023

    Relapsed or Refractory Mantle Cell Lymphoma (MCL) Trial in Duarte (BAFFR-CAR T cells)

    Recruiting
    • Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
    • BAFFR-CAR T cells
    • Duarte, California
      City of Hope Medical Center
    Oct 18, 2022

    NK/T Cell Lymphoma, Vascular Immunomother T Cell Lymphoma, Non-Hodgkin Lymphoma Trial in Guangzhou (GNC-038)

    Not yet recruiting
    • NK/T Cell Lymphoma
    • +2 more
    • Guangzhou, Guangdong, China
    • +1 more
    Jan 12, 2023

    Relapsed or Refractory B Cell Non-Hodgkin Lymphoma Trial (C-CAR066)

    Not yet recruiting
    • Relapsed or Refractory B Cell Non-Hodgkin Lymphoma
    • (no location specified)
    Mar 23, 2023

    Auto/Allo Tandem Transplant for Relapsed B-NHL

    Completed
    • Non Hodgkin Lymphoma
    • auto transplant followed by allo transplant
    • (no location specified)
    Oct 24, 2022

    Non-Hodgkin Lymphoma, Adult, Non-Hodgkin Lymphoma, Refractory, Non-Hodgkin Lymphoma, Relapsed Trial in United States (MT-601)

    Recruiting
    • Non-Hodgkin Lymphoma, Adult
    • +3 more
    • Duarte, California
    • +3 more
    Apr 4, 2023

    Non-hodgkin's Lymphoma Trial in Beijing (GNC-038)

    Recruiting
    • Non-hodgkin's Lymphoma
    • Beijing, Beijing, China
      Beijing Cancer Hospital
    Jan 12, 2023

    B-cell NHL, CLL Trial (CARCIK-CD19)

    Not yet recruiting
    • B-cell NHL
    • CLL
    • CARCIK-CD19
    • (no location specified)
    May 19, 2023

    Relapsed or Refractory Non-Hodgkin's Lymphoma Trial in Changsha, Suzhou (U16)

    Recruiting
    • Relapsed or Refractory Non-Hodgkin's Lymphoma
    • Changsha, Hunan, China
    • +1 more
    Mar 13, 2023

    Lymphoma, Non-Hodgkin Trial in China (DZD8586)

    Recruiting
    • Lymphoma, Non-Hodgkin
    • Beijing, Beijing, China
    • +5 more
    Apr 25, 2023

    Lymphoma, Non-Hodgkin Trial in Perth (DZD8586)

    Not yet recruiting
    • Lymphoma, Non-Hodgkin
    • Perth, Western Australia, Australia
      Linear Clinical Research Ltd
    Apr 20, 2023

    CD20-positive Non-Hodgkin Lymphoma Trial in Seoul (Rituximab + MG4101)

    Terminated
    • CD20-positive Non-Hodgkin Lymphoma
    • Rituximab + MG4101
    • Seoul, Korea, Republic of
      Seoul National University Hospital
    Oct 24, 2022

    Non-Hodgkin's Lymphoma Trial (MBS303)

    Not yet recruiting
    • Non-Hodgkin's Lymphoma
    • (no location specified)
    Apr 6, 2023

    Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma Trial in Chicago, Rochester, Cleveland (Venetoclax, Umbralisib, Ublituximab)

    Terminated
    • Chronic Lymphocytic Leukemia
    • Non-Hodgkin Lymphoma
    • Chicago, Illinois
    • +2 more
    Aug 19, 2022

    Relapsed/Refractory Non-Hodgkin Lymphoma Trial in Duarte, Amsterdam (BMS-986458, Rituximab)

    Not yet recruiting
    • Relapsed/Refractory Non-Hodgkin Lymphoma
    • Duarte, California
    • +1 more
    Oct 13, 2023

    Refractory Acute Lymphoblastic Leukemia, Relapsed Acute Lymphoblastic Leukemia Trial in Miami (Pevonedistat, Vincristine,

    Completed
    • Refractory Acute Lymphoblastic Leukemia
    • Relapsed Acute Lymphoblastic Leukemia
    • Miami, Florida
      University of Miami
    Oct 19, 2022

    Follicular B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma Recurrent, Mantle Cell Lymphoma Refractory Trial in Orange,

    Recruiting
    • Follicular B-cell Non-Hodgkin's Lymphoma
    • +7 more
    • MB-106
    • Orange, California
    • +3 more
    Nov 1, 2022

    Diffuse Large B Cell Lymphoma Trial in Shanghai (BTK inhibitor, PD-1 inhibitor)

    Not yet recruiting
    • Diffuse Large B Cell Lymphoma
    • BTK inhibitor
    • PD-1 inhibitor
    • Shanghai, China
      Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
    May 20, 2023

    B-cell Non-Hodgkin Lymphoma (B-NHL) Trial in Austin (UCART20x22, CLLS52)

    Recruiting
    • B-cell Non-Hodgkin Lymphoma (B-NHL)
    • UCART20x22
    • CLLS52
    • Austin, Texas
      Sarah Cannon - St. David South Austin Medical Center
    Dec 8, 2022

    B-cell Non-Hodgkin's Lymphoma Trial in Cincinnati (IMM0306)

    Recruiting
    • B-cell Non-Hodgkin's Lymphoma
    • Cincinnati, Ohio
      The Christ Hospital
    Apr 1, 2022

    B-cell Non-Hodgkin Lymphoma (B-NHL), B-cell Acute Lymphoblastic Lymphoma (B-ALL) Trial (PIT565)

    Not yet recruiting
    • B-cell Non-Hodgkin Lymphoma (B-NHL)
    • B-cell Acute Lymphoblastic Lymphoma (B-ALL)
    • PIT565
    • (no location specified)
    Jun 13, 2022

    Non Hodgkin Lymphoma Trial in Aurora (UCD19 CAR T Cells)

    Active, not recruiting
    • Non Hodgkin Lymphoma
    • UCD19 CAR T Cells
    • Aurora, Colorado
      University of Colorado Hospital
    Sep 1, 2022

    NHL, Adult Trial in Zhengzhou, Shanghai, Nanyang (APG-1252, Chidamide)

    Recruiting
    • NHL, Adult
    • Zhengzhou, Henanan, China
    • +3 more
    Jul 27, 2022

    Refractory Non-Hodgkin Lymphoma, Relapsed Non Hodgkin Lymphoma, Aggressive Non-Hodgkin Lymphoma Trial in Miami (Mosunetuzumab,

    Not yet recruiting
    • Refractory Non-Hodgkin Lymphoma
    • +2 more
    • Miami, Florida
      University of Miami
    Aug 3, 2022